免疫抑制剂

miǎn yì yì zhì jì
  • immunosuppressant;immunosuppressive agent;immunodepressant
免疫抑制剂免疫抑制剂
  1. SLE伴发月经不调的临床特征及与免疫抑制剂应用的关系

    Relation of systemic lupus erythematosus patients with abnormal menstruation and use of immunosuppressant

  2. 结论:FK506是一种强效免疫抑制剂,还可用于CsA不能逆转排斥反应的挽救治疗。

    CONCLUSION : FK506is a po_ wer immunosuppressant and can be used to treat CsA-resistant rejection .

  3. B组为保护组,气管移植术后给予免疫抑制剂环孢素A。

    Group B is the protection one : to offer the ciclosporin A after the tracheal transplantation .

  4. 为提高免疫抑制剂康乐霉素C的产量,采用γ射线对康乐霉素C产生菌&S-2-S-13的孢子进行了诱变育种。

    To improve the productivity of K-C , the spores of producing strain S-2-S-13 were breeded with γ - radiation .

  5. 结论免疫抑制剂的应用是治疗老年MG的重要措施。

    Conclusions Immunosuppressive treatments should be still an important therapeutic measure in the aged MG patients .

  6. Bcl-2对免疫抑制剂培养中胰岛细胞的保护作用

    Study on protection of Bcl-2 on islet cells cultured in immunosuppressive drugs

  7. 本文收集新近的相关进展信息,对治疗MG的新型免疫抑制剂研究进展进行综述。

    This article reviews study progresses of neotype immunodepressant of myasthenia gravis by collecting its lastest related information .

  8. 术后如未予免疫抑制剂,Lewis大鼠生存时间短暂。

    The Lewis recipients have short-term surviving after operation without given immunosuppressive drug .

  9. 免疫抑制剂治疗百草枯中毒的Meta分析

    Immunosuppressive therapy for paraquat poisoning : a Meta-analysis

  10. 结论PET对大剂量激素及免疫抑制剂疗效不佳的重症自身免疫性疾病疗效肯定,安全性高。

    Conclusion : PET is effective and safe in treating serious autoimmune disease after suboptimal response to large doses of steroids and immune inhibition .

  11. 结论SLE患者由于长期服用免疫抑制剂,易发生结核菌感染且临床表现不典型。

    Conclusion Because of long-term immunosuppressive agents therapy , patients with SLE are prone to tuberculosis infection .

  12. 糖皮质激素以外的免疫抑制剂在SR哮喘治疗中的意义值得进一步探讨。

    The therapeutic benefit of immuno inhibiting agents other than glucocorticoids in the management of SR asthma deserves further investigation .

  13. 免疫抑制剂FK506预处理对内毒素休克的干预作用

    Effect of FK506 pretreatment and its mechanism on endotoxin shock induced by LPS

  14. FK506是一种新型免疫抑制剂。

    FK506 is a new type immunosuppressant .

  15. 免疫抑制剂雷帕霉素对LPS免疫激发大鼠脑内免疫相关核团神经元Fos和nNOS表达的影响

    Effect of rapamycin on Fos and nNOS expression in the immunity correlative neurons challenged with lipopolysaccharide in rat

  16. 异种胰岛移植联合应用免疫抑制剂FK506和LEF的实验研究

    Pancreatic islet xenotransplantation with immunosuppressive drugs FK506 and LEF

  17. 而在醋酸可的松免疫抑制剂的作用下,巨噬细胞C3b受体数又较对照组明显下降(P<0.01)。

    While the YC-rosette forming rate of the macrophages from cortisone acetate-treated mice is lower than that of the control ( P < 0.01 ) .

  18. 他克莫司(Tacrolimus)是一种广泛使用的免疫抑制剂,可局部使用抑制角膜移植术后的排斥反应。

    Tacrolimus is one kind of widely used immunosuppressive agents , topical anti-rejection of corneal transplantation .

  19. 结果免疫抑制剂等药物局部治疗均可使甲状腺体积明显缩小,以E组最显著,治疗过程中肝、肾功能及血、尿常规无明显改变。

    Results Regression of enlargement of thyroid was obtained significantly after the local treatment , especially in group 5 . The liver and kidney functions with , blood routine showed no change .

  20. 他克莫司(Tacrolimus,FK506)是一种强效的免疫抑制剂,因在水中溶解度低限制了其应用。

    Tacrolimus ( FK506 ) is a potent immunosuppressant , but its poor solubility restricted its application .

  21. 新型免疫抑制剂SRL在器官移植受者中的转换治疗评价

    Evaluation of Conversion Treatment with SRL in Organ Transplant Recipients

  22. 伴随免疫抑制剂的治疗,急排组TH1、Tcl百分率及CD4/CD8比值减低。

    Following immune inhibitor treatment , the percentage of T_H1 and CD4 cells of All was decreased .

  23. 免疫抑制剂FK506的双重作用在神经再生治疗中具广阔的应用前景。

    The double role of immunosuppressive agent FK506 may have broad application prospect in treatment of nerve regeneration .

  24. 血清IgG含量、住院时间、激素及免疫抑制剂与医院感染显著相关(P<0.01)。

    The hospital infection showed close relationship with the level of IgG , stay in hospital , corticosteroid and immunosuppressive agents ( P < 0.01 ) .

  25. 目的探讨肾移植术后3个月内环孢菌素A(CsA)免疫抑制剂引起肝损害的治疗措施。

    Objective To investigate the therapeutic measures for liver injury by A ( CsA ) immunosuppressant within 3 months after renal transplantation .

  26. 目的观察新型免疫抑制剂来氟米特治疗狼疮肾炎(lupusnephritis,LN)的临床及病理疗效。

    Objective To investigate the clinical and pathological effect of leflunomide as a new immunosuppressive drug in the treatment of lupus nephritis ( LN ) .

  27. 纳入标准:符合TAO的诊断标准,均未行糖皮质激素、免疫抑制剂、局部放射等任何相关治疗。

    Inclusion criteria : accord with the standard of diagnosis of the TAO , all not line of glucocorticoid and immunosuppressants , any relevant local radiation therapy .

  28. OMT是一种免疫抑制剂。

    OMT is a kind of immunosuppressor .

  29. 烧伤后注射免疫抑制剂的动物(BⅠ组)肠壁病变严重,肠道菌群改变明显。

    In the group of burn plus DXM ( B + I ), the pathological changes of the wall of GI tract and the population level of enteric bacteria appeared more serious than those in the group B and I.

  30. 方法:对142例SLE患者外周血、骨髓象及应用糖皮质激素、免疫抑制剂治疗后变化情况进行总结分析。

    Methods : The blood and bone marrow pictures before and after treatment with steroids and immunosupressive agents were analyzed in 142 patients with SLE .